key: cord-0989137-vidpdltc authors: Mira Iglesias, A.; Mengual-Chulia, B.; Cano-Perez, L.; Garcia Rubio, J.; Tortajada-Girbes, M.; Carballido-Fernandez, M.; Mollar-Maseres, J.; Schwarz-Chavarri, G.; Garcia Esteban, S.; Puig Barbera, J.; Diez-Domingo, J.; Lopez-Labrador, F. X.; Disease, Valencia Hospital Network for the Study of Influenza and Respiratory Viruses title: Retrospective screening for SARS-CoV-2 among 5,800 hospitalizations related to influenza-like illness during the 2018-19 pre-pandemic and 2019-2020 pandemic influenza seasons in the VAHNSI network, Spain. date: 2021-05-24 journal: nan DOI: 10.1101/2021.05.24.21257402 sha: e7b7a147986eb5e1a81e505d7baf3f5abb6800b5 doc_id: 989137 cord_uid: vidpdltc On March 9 2020 the WHO Global Influenza Program (GIP) asked participant sites on the Global Influenza Hospital Surveillance Network (GIHSN) to contribute to data collection concerning severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We re-analysed 5,615 viral RNA archived samples collected prospectively from hospital admissions for influenza-like illness (ILI) in the Valencia Region of Spain by the VAHNSI network (4 hospitals, catchment area population 1,118,732) during the prepandemic 2018/2019 (n=4,010) and pandemic 2019/2020 (n=1,823) influenza seasons, for the presence of SARS-CoV-2. We did not find evidence for community-acquired SARS-CoV-2 infection in hospital admissions for ILI in our region before 8 March 2020. The first case of coronavirus disease 2019 (COVID-19) due to severe acute respiratory syndrome 45 coronavirus (SARS-CoV-2) was detected in Wuhan (Hubei province, China) at the end of 2019 46 and the virus rapidly spread to other Chinese provinces and countries (1) . As of 3 June 2020, the 47 World Health Organization (WHO) had already reported the presence of SARS-CoV-2 in 54 48 different European countries (2). In Spain, the first imported and locally acquired COVID-19 cases 49 were detected on 31 January, and 26 February 2020, respectively (3, 4). Since then, until 50 beginning of June, Spain accounted for 240,660 confirmed cases and 27,133 deaths. Among total 51 registered deaths, 86% were in people aged 70 or older and 95% had previous underlying chronic 52 conditions (5) . Symptomatology described by SARS-CoV-2-infected patients was almost identical 53 to the common influenza-like illness (ILI) symptoms (6, 7), and COVID-19 cases may have 54 occurred in Spain earlier than previously recognized (8). Besides, there is no data available on 55 potential SARS-CoV-2 circulation during the prepandemic 2018/2019 influenza season. 56 57 Methods 58 Every influenza season, from November to March/April, the Valencia Hospital Surveillance 59 Network for the Study of Influenza and Other Respiratory Viruses (VAHNSI) network conducts a 60 prospective active-surveillance study on respiratory viral infections in 4 hospitals, providing 61 healthcare to 1,118,732 (22% of total) inhabitants from the Valencia Region of Spain ( Figure 1 ). 62 Our network is integrated in the Global Influenza Hospital Surveillance Network (GIHSN) sharing 63 data with the WHO GIP (www.gihsn.org/). Full-time dedicated nurses screen all hospitalized 64 patients discharged from the Emergency Department if they referred a complain possibly 65 related to a respiratory infection. Patients are included in the study if they are resident in the 66 catchment area of one of the participating hospitals, non-institutionalised and not discharged 67 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. illness (ILI) case definition (9), defined as the presence of, at least, one systemic symptom (fever 69 or feverishness, malaise, myalgia or headache) and, at least, one respiratory symptom 70 (shortness of breath, sore throat or cough), with an onset of symptoms in the 7 days prior to 71 admission. For children less than 5 years old, we only require an onset of one symptom (Table 72 S1) in the 7 days prior to admission. Finally, patients need to be in hospital between 8 and 48 73 hours to be enrolled and swabbed (combined nasopharyngeal and oropharyngeal in universal 74 transport medium), after written informed consent. Clinical and demographic characteristics 75 from patients were obtained by a face-to-face interview or by consulting medical records. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 24, 2021. To our knowledge, our study is the first comprehensive screening for SARS-CoV-2 in ILI cases at 121 the population level in the prepandemic period in Europe. We describe here the first SARS-122 CoV-2 admission in the Valencia Region without travel history and thus likely due to 123 community transmission in early March, 2020. The infected patient was an old diabetic man in 124 his late 70's who was also developing a neoplasia. It is widely known that COVID19 mainly 125 affects elderly people (12, 13) (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The first SARS-CoV-2 cases in hospital admissions in Europe had been identified at the end of 171 January or early February 2020 as related to travel to, or to contacts with, travellers from China 172 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. supports the Global Influenza Hospital Surveillance Network (see www.gihsn.org for more 206 details). The sponsor did not participate in the study design, data analysis and interpretation, 207 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 24, 2021. ; https://doi.org/10.1101/2021.05.24.21257402 doi: medRxiv preprint Situation report -1 Coronavirus disease (COVID-19) Situation Report-135: World Healh Organization Instituto de Salud Carlos III (ISCIII) Informe Covid-2019 no 1 Madrid: ISCIII; 2020 Informe sobre los casos de COVID-19 confirmados en 227 Madrid: ISCIII; 2020 Enfermedad por el coronavirus (COVID-19) 233 04.06.2020: Ministerio de Sanidad China/documentos/Actualizacion_126_COVID-19.pdf Clinical features of patients infected with 237 2019 novel coronavirus in Wuhan Coronavirus disease 2019 in elderly 239 patients: Characteristics and prognostic factors based on 4-week follow-up Excess cases 242 of influenza suggest an earlier start to the coronavirus epidemic in Spain than official figures 243 tell us: an analysis of primary care electronic medical records from over 6 million people from 244 Clinical Characteristics of Coronavirus 260 Disease 2019 in China Clinical features of COVID-19 in elderly patients: A comparison 262 with young and middle-aged patients Comorbid Chronic Diseases are Strongly Correlated with 264 Disease Severity among COVID-19 Patients: A Systematic Review and Meta-Analysis Influence of diabetes mellitus on the 267 severity and fatality of SARS-CoV-2 infection. Diabetes, obesity & metabolism Analysis of clinical features and outcomes 269 of 161 patients with severe and critical COVID-19: A multicenter descriptive study Autopsy findings from the first known death from Severe 273 Acute Respiratory Syndrome SARS-CoV-2 in Spain Working group for the surveillance and control of COVID-19 in Spain. The first wave of the 276 COVID-19 pandemic in Spain: characterisation of cases and risk factors for severe outcomes SARS-CoV-2 detection in 280 patients with influenza-like illness A 283 Founder Effect Led Early SARS-CoV-2 Transmission in Spain Retrospective 286 search of SARS-CoV-2 in respiratory samples in Vallès Occidental SARS-CoV-2 Circulation in Rome (Italy) during the Pre-Pandemic Period: Results of a 291 Retrospective Surveillance Severe Acute Respiratory Syndrome Coronavirus 2 Emergence Amidst Community-Acquired 298 Respiratory Viruses. The Journal of Infectious Diseases 2020 1/8/2021 SARS-CoV-2 and Influenza and the impact of coinfection on disease severity: A test negative 301 design Severe Acute Respiratory Syndrome Coronavirus 2 into Europe. Emerging Infectious Disease 304 journal 2020 Clinical and 306 virological data of the first cases of COVID-19 in Europe: a case series First cases of 309 coronavirus disease 2019 (COVID-19) in the WHO European Region CoV-2 was already spreading in France in late Unexpected 318 detection of SARS-CoV-2 antibodies in the prepandemic period in Italy Sample Pooling as a Strategy to Detect Community 321 Transmission of SARS-CoV-2. JAMA; 2020 All rights reserved. No reuse allowed without permission.(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this preprint this version posted May 24, 2021. ; https://doi.org/10.1101/2021.05.24.21257402 doi: medRxiv preprint All rights reserved. No reuse allowed without permission.(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The timing for the first ILI admission positive for SARS-CoV-2 is indicated. 333 334 First SARS-CoV-2 ILI admission All rights reserved. No reuse allowed without permission.(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this preprint this version posted May 24, 2021. ; https://doi.org/10.1101/2021.05.24.21257402 doi: medRxiv preprint